» Articles » PMID: 38306267

Ferroptosis-Based Therapeutic Strategies Toward Precision Medicine for Cancer

Overview
Journal J Med Chem
Specialty Chemistry
Date 2024 Feb 2
PMID 38306267
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis is a type of iron-dependent programmed cell death characterized by the dysregulation of iron metabolism and the accumulation of lipid peroxides. This nonapoptotic mode of cell death is implicated in various physiological and pathological processes. Recent findings have underscored its potential as an innovative strategy for cancer treatment, particularly against recalcitrant malignancies that are resistant to conventional therapies. This article focuses on ferroptosis-based therapeutic strategies for precision cancer treatment, covering the molecular mechanisms of ferroptosis, four major types of ferroptosis inducers and their inhibitory effects on diverse carcinomas, the detection of ferroptosis by fluorescent probes, and their implementation in image-guided therapy. These state-of-the-art tactics have manifested enhanced selectivity and efficacy against malignant carcinomas. Given that the administration of ferroptosis in cancer therapy is still at a burgeoning stage, some major challenges and future perspectives are discussed for the clinical translation of ferroptosis into precision cancer treatment.

Citing Articles

Repurposing of the Antipsychotic Trifluoperazine Induces SLC7A11/GPX4- Mediated Ferroptosis of Oral Cancer via the ROS/Autophagy Pathway.

Tsai S, Chang P, Lin Y, Huang P, Chen J, Lin C Int J Biol Sci. 2024; 20(15):6090-6113.

PMID: 39664583 PMC: 11628333. DOI: 10.7150/ijbs.99859.


Histidine phosphatase-ferroptosis crosstalk modulation for efficient hepatocellular carcinoma treatment.

Qin Y, Ling X, Li Y, Wang J, Wang J, Rong Z J Nanobiotechnology. 2024; 22(1):622.

PMID: 39402673 PMC: 11476632. DOI: 10.1186/s12951-024-02918-2.


The significance of ferroptosis in renal diseases and its therapeutic potential.

Jiang M, Wu S, Xie K, Zhou G, Zhou W, Bao P Heliyon. 2024; 10(16):e35882.

PMID: 39220983 PMC: 11363859. DOI: 10.1016/j.heliyon.2024.e35882.


Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects.

Lu Y, Xie X, Luo L Apoptosis. 2024; 29(11-12):1914-1943.

PMID: 39008197 DOI: 10.1007/s10495-024-01997-8.


Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches.

Luo Y, Bai X, Zhang L, Hu Q, Zhang N, Cheng J Drug Des Devel Ther. 2024; 18:2485-2529.

PMID: 38919962 PMC: 11198730. DOI: 10.2147/DDDT.S472178.